Clinical trial · Observational
Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol
Hematologic Toxicity Observation of the TPF Medical Protocol. Description of the Impact of Febrile Neutropenia in Patients Who Receive the Chemotherapy of the TPF Medical Protocol in Head and Neck Cell Carcinoma
NCT01268878CI-TRIAL-00013278OTOHTPFcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The ending of this study is to describe the effect of febrile neutropenia on patients who receive a chemotherapy by docetaxel+cisplatin+fluorouracil(TPF).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Squamous Cell Head and Neck Carcinoma | Head and Neck Squamous Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- biologic blood counts
- timeFrame
- blood test before every chemotherapy up to 4 months
- description
- evaluation of medical status evaluation of hematologic toxicity description of clinic toxicity: fever, sepsis..
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients with histologically proved head and neck squamous cell carcinoma * age: more than 18 * patients who are beginning a chemotherapy (docetaxel+cisplatin+ 5FU) * patients must have been informed of automatic data processing concerning them. Exclusion Criteria: * previous chemotherapy for the head and neck squamous cell carcinoma * previous chemotherapy for an other cancer in the two years before * intercurrent illness that could significantly interfere with chemotherapy such as HIV infection, infection or active febrile illness, a chronic intestinal disease
References
Publications (0)
Data not yet available
No reference posted for this study.